PDL BioPharma Inc (NASDAQ:PDLI)

2.83
Delayed Data
As of 3:59pm ET
 -0.025 / -0.88%
Today’s Change
1.68
Today|||52-Week Range
3.47
+6.97%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for PDL BioPharma Inc have a median target of 2.49, with a high estimate of 2.49 and a low estimate of 2.49. The median estimate represents a -12.14% decrease from the last price of 2.83.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in PDL BioPharma Inc. This rating has held steady since February, when it was downgraded from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.08
Sales
$1.5M
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 138.46%
 
 
 
 
 
 
Growthannually 40.99%
 
 
 
 
 
 

Sales

Growthquarterly -74.98%
 
 
 
 
 
 
Growthannually -73.36%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.